Angelopoulou E, Bougea A, Paudel Y, Georgakopoulou V, Papageorgiou S, Piperi C
Medicina (Kaunas). 2023; 59(6).
PMID: 37374342
PMC: 10301401.
DOI: 10.3390/medicina59061138.
Fischer D, Auinger P, Goudreau J, Paumier K, Cole-Strauss A, Kemp C
Front Neurol. 2022; 13:1053591.
PMID: 36468063
PMC: 9713476.
DOI: 10.3389/fneur.2022.1053591.
Szarowicz C, Steece-Collier K, Caulfield M
Int J Mol Sci. 2022; 23(14).
PMID: 35887357
PMC: 9319713.
DOI: 10.3390/ijms23148011.
Azman K, Zakaria R
Int J Mol Sci. 2022; 23(12).
PMID: 35743271
PMC: 9224343.
DOI: 10.3390/ijms23126827.
Sobolczyk M, Boczek T
Front Cell Neurosci. 2022; 16:889939.
PMID: 35663426
PMC: 9161693.
DOI: 10.3389/fncel.2022.889939.
Pramipexole Inhibits Neuronal Apoptosis in Rats with Parkinson's Disease.
Sun Y, Cui B, Ye L, Hu Y, Pan Y
J Healthc Eng. 2022; 2022:7002630.
PMID: 35463692
PMC: 9020956.
DOI: 10.1155/2022/7002630.
BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease.
Sortwell C, Hacker M, Fischer D, Konrad P, Davis T, Neimat J
Neuromodulation. 2021; 25(6):846-853.
PMID: 34288271
PMC: 8770717.
DOI: 10.1111/ner.13504.
Effects of vagus nerve stimulation are mediated in part by TrkB in a parkinson's disease model.
Farrand A, Helke K, Aponte-Cofresi L, Gooz M, Gregory R, Hinson V
Behav Brain Res. 2019; 373:112080.
PMID: 31301412
PMC: 6701465.
DOI: 10.1016/j.bbr.2019.112080.
BDNF Polymorphism: A Review of Its Diagnostic and Clinical Relevance in Neurodegenerative Disorders.
Shen T, You Y, Joseph C, Mirzaei M, Klistorner A, Graham S
Aging Dis. 2018; 9(3):523-536.
PMID: 29896439
PMC: 5988606.
DOI: 10.14336/AD.2017.0717.
BDNF in the Aged Brain: Translational Implications for Parkinson's Disease.
Mercado N, Collier T, Sortwell C, Steece-Collier K
Austin Neurol Neurosci. 2018; 2(2).
PMID: 29726549
PMC: 5929154.
Neurotrophic factors in Alzheimer's and Parkinson's diseases: implications for pathogenesis and therapy.
Sampaio T, Savall A, Gutierrez M, Pinton S
Neural Regen Res. 2017; 12(4):549-557.
PMID: 28553325
PMC: 5436343.
DOI: 10.4103/1673-5374.205084.
Antidepressant-like effects of ginsenoside Rg3 in mice via activation of the hippocampal BDNF signaling cascade.
You Z, Yao Q, Shen J, Gu Z, Xu H, Wu Z
J Nat Med. 2016; 71(2):367-379.
PMID: 28013484
DOI: 10.1007/s11418-016-1066-1.
FTY720/Fingolimod Reduces Synucleinopathy and Improves Gut Motility in A53T Mice: CONTRIBUTIONS OF PRO-BRAIN-DERIVED NEUROTROPHIC FACTOR (PRO-BDNF) AND MATURE BDNF.
Vidal-Martinez G, Vargas-Medrano J, Gil-Tommee C, Medina D, Garza N, Yang B
J Biol Chem. 2016; 291(39):20811-21.
PMID: 27528608
PMC: 5034069.
DOI: 10.1074/jbc.M116.744029.
Brain-derived neurotrophic factor serum levels correlate with cognitive performance in Parkinson's disease patients with mild cognitive impairment.
Costa A, Peppe A, Carlesimo G, Zabberoni S, Scalici F, Caltagirone C
Front Behav Neurosci. 2015; 9:253.
PMID: 26441580
PMC: 4569860.
DOI: 10.3389/fnbeh.2015.00253.
Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives.
Veenvliet J, Smidt M
Cell Mol Life Sci. 2014; 71(24):4703-27.
PMID: 25064061
PMC: 11113784.
DOI: 10.1007/s00018-014-1681-5.
Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease.
Rodrigues T, Jeronimo-Santos A, Outeiro T, Sebastiao A, Diogenes M
Drugs Aging. 2014; 31(4):239-61.
PMID: 24610720
DOI: 10.1007/s40266-014-0160-x.
Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders.
Ramanan V, Saykin A
Am J Neurodegener Dis. 2013; 2(3):145-75.
PMID: 24093081
PMC: 3783830.
BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases.
Lu B, Nagappan G, Guan X, Nathan P, Wren P
Nat Rev Neurosci. 2013; 14(6):401-16.
PMID: 23674053
DOI: 10.1038/nrn3505.
Role of BDNF in central motor structures and motor diseases.
He Y, Zhang X, Yung W, Zhu J, Wang J
Mol Neurobiol. 2013; 48(3):783-93.
PMID: 23649659
DOI: 10.1007/s12035-013-8466-y.
Pharmacological therapy in Parkinson's disease: focus on neuroprotection.
Kincses Z, Vecsei L
CNS Neurosci Ther. 2010; 17(5):345-67.
PMID: 20438581
PMC: 6493808.
DOI: 10.1111/j.1755-5949.2010.00150.x.